VERAXA Biotech advances VXA-222 bispecific ADC program with OmniAb

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/20/2026

1. TGT
2. EL
3. SPY
4. WMT
5. ADI
6. ROST
7. BILL
8. MRNA
9. MRK
10. COTY

Go back to VERAXA Biotech advances VXA-222 bispecific ADC program with OmniAb
(NASDAQ: OABI) Delayed: 4.30 +0.11 (2.63%)
Previous Close $4.19    52 Week High $ 
Open $4.19    52 Week Low $ 
Day High $4.59    P/E N/A 
Day Low $4.16    EPS $ 
Volume 2,252,643       

(NASDAQ: VRXA) Delayed: 1.89 +0.03 (1.61%)
Previous Close $1.86    52 Week High $ 
Open $1.88    52 Week Low $ 
Day High $1.95    P/E N/A 
Day Low $1.85    EPS $ 
Volume 37,149